Pages

Wednesday, June 30, 2021

Pre-market summary on your portfolio Delacrox

Latest 1 day change: AA +3.99%, AGR -1.32%, ARNC +0.59%, BKR +0.13%, BMY -0.20%, CNL n/a, CTVA -0.14%, CVX -0.22%, D -2.30%, DD +0.01%, DE -0.27%, DOW +0.13%, DUK -1.89%, FE -1.37%, HE -1.60%, HWM -0.62%, IBM +0.18%, JNJ +0.01%, K -0.75%, KO -0.74%, MBKL 0.0, MMM -0.24%, PFE -0.05%, PG -0.68%, PSX -0.36%, RTX -0.79%, T -0.42%, TE n/a, VTRS +0.97%, WNR n/a, XOM -0.62%

Add or remove stocks or check stock prices now.

BREAKING:  Inflation Hits 13-Year High

If you've noticed the bills going up for basic necessities like food, fuel, and shelter… You're not alone. Neither are you alone with your investments. Because our team at High Dividend Opportunities stands ready with high-yield, high-quality dividend stocks targeting 8-10% yields.  Get the current picks for free »

Breaking News

JNJ JNJ COVID-19 shot shows efficacy against variants in lab-based study: NIH

BMY Bristol Myers' Opdivo + Yervoy combo OK'd in Europe for colorectal cancer

Analysis

AA Alcoa: China May Stop This Aluminum Rally, But It Is Not Over by Harrison Schwartz

T AT&T: Hidden Costs by Stone Fox Capital

JNJ Johnson & Johnson: Any Share Price Dip Could Be A Buy Opportunity by Robert Honeywill

KO Coca-Cola: Cristiano Ronaldo Doesn't Determine Dividend Payouts by Pearl Gray Equity and Research

Related Analysis

BMY Tracking David Rolfe's Wedgewood Partners Portfolio - Q1 2021 Update by John Vincent

CVX, XOM Is Hurried Decarbonization Causing An Oil Crisis? by WisdomTree

JNJ Endo International: Bankruptcy Seems Like The Only Practical Option by CashFlow Hunter

CVX 30 Reliable Retiree Dividend Equities Report 6 Ideal Dogs For July by Fredrik Arnold

JNJ Arbutus' Recent Hepatitis B Data At EASL 2021 Makes The Case For A Great Long-Term Investment by Terry Chrisomalis

BMY Prothena: Well-Positioned In Parkinson's And Alzheimer's by Tarun Chandra, CFA

AA AVUV: Small Cap Value ETF Review by Fred Piard

JNJ Tracking John Rogers' Ariel Investments Portfolio - Q1 2021 Update by John Vincent

Press Releases

BMY Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy (Business Wire)

IBM OneTen Launches Technology Platform to Create and Enable One Million Career Opportunities for Black Talent Over the Next 10 Years (PR Newswire)

IBM KPMG Automates, Accelerates and Enhances Artificial Intelligence Workflows with Red Hat OpenShift (Business Wire)

T Xandr Introduces First of Its Kind Forecasting and Analysis Across CTV and Linear Addressable (Business Wire)

AGR AVANGRID Schedules Second Quarter 2021 Earnings Release and Conference Call (Business Wire)


Download Seeking Alpha for your Phone or Tablet
     

Why are you receiving this? You subscribed to Daily Portfolio Summary on your portfolio Delacrox at Seeking Alpha. Unsubscribe here.

To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.

Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017